People who are immunocompromised (who have weakened immune defenses) can also have widespread rash when others might only have a localized rash. An example includes disseminated shingles in people ...

This Gabrylly chair is specifically designed to ease pressure in your neck and back, with extra attention paid to the headrest. Unlike many chairs with stiff or barely adjustable head supports ...

An itchy rash with blisters can be caused by an allergic reaction ... With HSV-2, diagnosis and treatment are important for controlling symptoms and your risk of other infections, such as human ...

In 2019, President Donald Trump launched an ambitious new health program with a singular aim: reduce HIV transmission in America by 90 percent. Six years and a change of president later ...

The excess saliva that babies drool when teething can irritate the skin around their mouth, as well as their cheeks, chin, neck ... a second rash on the arms, legs, chest, back, or buttocks.

Around this time, 1987, HIV had emerged as a major health threat. Using recombinant vaccinia viruses expressing HIV gene products and synthetic peptides, Doug Nixon, Frances Gotch and I were able ...

The current presidential administration has ended funding for the Center for HIV/AIDS Vaccine Development (CHAVD), a move that researchers say will likely set efforts to end HIV globally back by a ...

The ball is held to raise money and awareness for HIV/AIDS research. It began in 1994. Things kicked off with red-carpet arrivals. And if there's a red carpet, we know it's where we often find ...

It's a rash that's often the first symptom of Lyme ... and it's in the middle of your back or behind your knee, you don't really look at those areas usually in the mirror," Aucott says.

Johannesburg - A number of issues remained unresolved before the HIV testing of pupils could start during the first school term of 2012, said the Basic Education Ministry on Tuesday. "[Minister Angie ...

But recently, several promising mRNA HIV-vaccine candidates have slammed up against a technical roadblock. In two small clinical trials, 7 to 18 percent of participants developed rashes and other ...